Botanix Pharmaceuticals Limited
BXPHF
$0.09
$0.002.62%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -2.12% | -73.00% | 2.75% | -273.77% | -0.21% |
| Total Depreciation and Amortization | 2.11% | -1.35% | -2.75% | 1,675.36% | 0.00% |
| Total Amortization of Deferred Charges | 2.11% | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.12% | 2,699.34% | 2.75% | -129.87% | 0.20% |
| Change in Net Operating Assets | -2.12% | -- | -- | -- | 0.21% |
| Cash from Operations | -2.12% | -51.27% | 2.75% | -611.57% | -0.21% |
| Capital Expenditure | -2.12% | -108.14% | 2.64% | -20.24% | 0.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 100.00% | 2.78% | 75.33% | -0.21% |
| Cash from Investing | -2.12% | 77.93% | 2.76% | 73.07% | -0.21% |
| Total Debt Issued | 0.00% | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -112.66% | 0.00% | -- | -- |
| Issuance of Common Stock | 0.00% | 8,558.01% | 0.00% | -99.36% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00% | -- | -- | -- | 0.00% |
| Cash from Financing | 2.12% | 15,512.26% | -2.68% | -99.40% | 0.21% |
| Foreign Exchange rate Adjustments | -2.15% | -239.02% | -2.70% | -40.12% | 0.12% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.12% | 151.54% | 2.75% | -151.46% | 0.21% |